4.7 Article

Interferon-γ ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection A Clinical Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Critical Care Medicine

Relevance of Latent TB Infection in Areas of High TB Prevalence

Surendra K. Sharma et al.

Review Immunology

Immunological biomarkers of tuberculosis

Gerhard Walzl et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Point-of-care Arkansas method for measuring adherence to treatment with isoniazid

Renata L. Guerra et al.

RESPIRATORY MEDICINE (2010)

Article Cardiac & Cardiovascular Systems

Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak

Seung Heon Lee et al.

RESPIRATORY MEDICINE (2010)

Article Medicine, General & Internal

Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection

Philip C. Hill et al.

PLOS MEDICINE (2007)

Article Critical Care Medicine

Latent tuberculosis infection treatment and T-Cell responses to Mycobacterium tuberculosis-specific antigens

Cynthia B. E. Chee et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Critical Care Medicine

Dynamic antigen-specific point-source exposure to T-cell responses after Mycobacterium tuberculosis

Katie Ewer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

Article Genetics & Heredity

Sub-Saharan African Coding Sequence Variation and Haplotype Diversity at the NAT2 Gene

Etienne Patin et al.

HUMAN MUTATION (2006)

Article Infectious Diseases

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases

Alexander M. Aiken et al.

BMC INFECTIOUS DISEASES (2006)

Article Medicine, Research & Experimental

Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop

VG De Gruttola et al.

CONTROLLED CLINICAL TRIALS (2001)